Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: A receiver operating characteristic curve analysis

Annals of Surgical Oncology

Volumn 14, Issue 2, 2007, Pages 417-423

  Körner, Hartwig ^a,b   Söreide, Kjetil ^a   Stokkeland, Pål Johan ^a   Söreide, Jon Arne ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

CEA; Colorectal cancer; Diagnostic accuracy; Follow up; Recurrence; ROC analysis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33846620129     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9060-6     Document Type: Article

References (33)

1. Weitz J, Koch M, Debus J, et al. Colorectal cancer. Lancet 2005; 365:153-65.
2. Biggs CG, Ballantyne GH. Sensitivity versus cost effectiveness in postoperative follow-up for colorectal cancer. Curr Opin Gen Surg 1994; 94-102.
3. Bruinvels DJ, Stiggelbout AM, Kievit J, et al. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 1994; 219:174-82.
4. Detry R. Follow-up after curative surgery for colorectal cancer. Acta Gastroenterol Belg 2001; 64:268-71.
5. Körner H, Söreide K, Stokkeland PJ, Söreide JA. Systematic follow-up after curative surgery for colorectal cancer in Norway: A population-based audit of effectiveness, costs, and compliance. J Gastrointest Surg 2005; 9:320-8.
6. Audisio RA, Setti-Carraro P, Segala M, et al. Follow-up in colorectal cancer patients: a cost-benefit analysis. Ann Surg Oncol 1996; 3:349-57.
7. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15:938-46.
8. Weber SM, Jarnagin WR, DeMatteo RP, et al. Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 2000; 7:643-50.
9. Wanebo JH, Stearns M, Schwartz MK. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. Ann Surg 1978; 188:481-93.
10. Wood CB, Ratcliffe JG, Burt RW, et al. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer. Br J Surg 1980; 67:46-8.
11. Persijn JP, Hart AA. Prognostic significance of CEA in colorectal cancer: a statistical study. J Clin Chem Clin Biochem 1981; 19:1117-23.
12. Armitage NC, Davidson A, Tsikos D, Wood CB. A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer. Clin Oncol 1984; 10:141-7.
13. Northover J. The use of prognostic markers in surgery for colorectal cancer. Eur J Cancer 1995; 31A:1207-9.
14. Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?. Clin Chem 2001; 47:624-30.
15. Wichmann MW, Müller C, Lau-Werner U, et al. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer. Langenbecks Arch Surg 2000; 385:271-5.
16. Chau I, Allen MJ, Cunningham D, et al. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol 2004; 22:1420-9.
17. Kievit J. Follow-up of patients with colorectal cancer: numbers needed to test and treat. Eur J Cancer 2002; 38:986-99.
18. Wichmann MW, Lau-Werner U, Müller C, et al. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Anticancer Res 2000; 20:4953-5.
19. Robertson EA, Zweig MH. Use of receiver operating characteristic curves to evaluate the clinical performance of analytical systems. Clin Chem 1981; 27:1569-74.
20. Zweig MH. Evaluation of the clinical accuracy of laboratory tests. Arch Pathol Lab Med 1988; 112:383-6.
21. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39:561-77.
22. Carriquiry LA, Pineyro A. Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?. Dis Colon Rectum 1999; 42:921-9.
23. Stajic S, Novakovic R, Kostic N, et al. The importance of monitoring colorectal adenomas by tumor markers (ROC analysis). Med Pregl 1993; 46:69-71.
24. Vallejo J, Torres-Avisbal M, Contreras P, et al. CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis. Rev Esp Med Nucl 1999; 18:281-6.
25. Pasanen PA, Eskelinen M, Partanen K, et al. Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study. Br J Cancer 1993; 67:852-5.
26. Silver HK, Archibald BL, Ragaz J, Coldman AJ. Relative operating characteristic analysis and group modeling for tumor markers: comparison of CA 15.3, carcinoembryonic antigen, and mucin-like carcinoma-associated antigen in breast carcinoma. Cancer Res 1991; 51:1904-9.
27. Norwegian Gastro-Intestinal Cancer Group (NGICG) Kolorektalcancer og Analcancer. En Veiledning for Leger Oslo: NGICG; 1999.
28. Altman DG. Diagnostic tests. In: Practical Statistics for Medical Research. London: Chapman and Hall, 1991:411-416.
29. Bhandari M, Guyatt GH. How to appraise a diagnostic test. World J Surg 2005; 29:561-6.
30. Moertel CG, Fleming TR, Macdonald JS, et al. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993; 270:943-7.
31. Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 1991; 44:763-70.
32. Fukuda I, Yamakado M, Kiyose H. Influence of smoking on serum carcinoembryonic antigen levels in subjects who underwent multiphasic health testing and services. J Med Syst 1998; 22:89-93.
33. Wanebo HJ. Cancer trends: the role of CEA in managing colorectal cancer. VA Med 1983; 110:103-8.